New study proves safety of novel, wireless pacing system, WiSE-CRT (Wireless Stimulation Endocardially for cardiac resynchronization therapy) two years after implantation. The study is the first to report on the medium-long term feasibility of the leadless pacing system for heart failure patients and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
Search for "" returned 177 matches
A new study found that dementia rates increase with delays in starting anticoagulation treatment for atrial fibrillation (AF). The large study included more than 76,230 AF patients with no prior history of dementia that were treated with an antiplatelet or warfarin. The results were presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions, and show that warfarin, in particular, can increase the risk of dementia long-term.
Today, the Heart Rhythm Society (HRS) in joint partnership with the European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Society (ECAS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) issued an international consensus statement that provides a state-of-the-art review of the indications, techniques, and outcomes of catheter and surgical ablation of atrial fibrillation (AF). The 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, first issued in 2007, and again in 2012, represents a state-of-the art review of the field of catheter and surgical ablation of AF. This document is a complete and comprehensive revision of the 2012 statement and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.
The 2017 Atrial Fibrillation (AFib) Screening and Education Initiative is designed to increase awareness of AFib among patients and caregivers, support the development of an AFib screening and education program, and collect non-scientific data of patients screened.
The Heart Rhythm Society (HRS) issued an international consensus statement that comprehensively addresses lead management for patients with cardiovascular implantable electronic devices (CIEDs). The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction was presented today at the 10th Asia Pacific Heart Rhythm Society (APHRS) Annual Scientific Session held in conjunction with the Annual Meeting of the Japanese Heart Rhythm Society (JHRS). The expert consensus statement is the first to have a comprehensive discussion of lead management issues, including lead extraction, and is an update to the 2009 HRS lead extraction clinical document.
WASHINGTON, DC – The American College of Cardiology (ACC), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography and Interventions (SCAI) have announced a partnership to develop new modules to help subspecialty cardiologists potentially meet collaborative maintenance pathway requirements equivalent to satisfying the ABIM’s current 10-year MOC examination.
Working in concert, the Society for Cardiovascular Angiography and Interventions (SCAI), the Heart Rhythm Society (HRS), the Alliance of Cardiovascular Professionals (ACVP) and the Intersocietal Accreditation Commission (IAC) announce the release of the IAC Cardiovascular Catheterization accreditation program. Representatives from these organizations, as well as pediatric cardiologist and nurse members-at-large, have developed standards and created the accreditation process. The program establishes quality metrics and provides a rigorous evaluation through clinical peer review of the facility’s processes, documentation, and imaging critical to quality patient care as it relates to cardiovascular catheterization procedures.